Confirmation of family cancer history reported in a population-based survey
- PMID: 21562245
- PMCID: PMC3096799
- DOI: 10.1093/jnci/djr114
Confirmation of family cancer history reported in a population-based survey
Abstract
Background: Knowledge of family cancer history is essential for estimating an individual's cancer risk and making clinical recommendations regarding screening and referral to a specialty cancer genetics clinic. However, it is not clear if reported family cancer history is sufficiently accurate for this purpose.
Methods: In the population-based 2001 Connecticut Family Health Study, 1019 participants reported on 20 578 first-degree relatives (FDR) and second-degree relatives (SDR). Of those, 2605 relatives were sampled for confirmation of cancer reports on breast, colorectal, prostate, and lung cancer. Confirmation sources included state cancer registries, Medicare databases, the National Death Index, death certificates, and health-care facility records. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for reports on lung, colorectal, breast, and prostate cancer and after stratification by sex, age, education, and degree of relatedness and used to estimate report accuracy. Pairwise t tests were used to evaluate differences between the two strata in each stratified analysis. All statistical tests were two-sided.
Results: Overall, sensitivity and positive predictive value were low to moderate and varied by cancer type: 60.2% and 40.0%, respectively, for lung cancer reports, 27.3% and 53.5% for colorectal cancer reports, 61.1% and 61.3% for breast cancer reports, and 32.0% and 53.4% for prostate cancer reports. Specificity and negative predictive value were more than 95% for all four cancer types. Cancer history reports on FDR were more accurate than reports on SDR, with reports on FDR having statistically significantly higher sensitivity for prostate cancer than reports on SDR (58.9% vs 21.5%, P = .002) and higher positive predictive value for lung (78.1% vs 31.7%, P < .001), colorectal (85.8% vs 43.5%, P = .004), and breast cancer (79.9% vs 53.6%, P = .02).
Conclusions: General population reports on family history for the four major adult cancers were not highly accurate. Efforts to improve accuracy are needed in primary care and other health-care settings in which family history is collected to ensure appropriate risk assessment and clinical care recommendations.
Figures
Comment in
-
Family cancer history: healthy skepticism required.J Natl Cancer Inst. 2011 May 18;103(10):776-7. doi: 10.1093/jnci/djr142. Epub 2011 May 11. J Natl Cancer Inst. 2011. PMID: 21562244 No abstract available.
Similar articles
-
Family cancer history: healthy skepticism required.J Natl Cancer Inst. 2011 May 18;103(10):776-7. doi: 10.1093/jnci/djr142. Epub 2011 May 11. J Natl Cancer Inst. 2011. PMID: 21562244 No abstract available.
-
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.Public Health Genomics. 2010;13(7-8):495-503. doi: 10.1159/000294469. Epub 2010 Apr 9. Public Health Genomics. 2010. PMID: 20389042 Free PMC article.
-
Validation of family history data in cancer family registries.Am J Prev Med. 2003 Feb;24(2):190-8. doi: 10.1016/s0749-3797(02)00593-7. Am J Prev Med. 2003. PMID: 12568826
-
Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.JAMA. 2004 Sep 22;292(12):1480-9. doi: 10.1001/jama.292.12.1480. JAMA. 2004. PMID: 15383520 Review.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
-
The Use of National Cancer Registry Data for Breast Cancer Family History Assessment in Premenopausal Women.J Clin Med. 2024 Jul 31;13(15):4473. doi: 10.3390/jcm13154473. J Clin Med. 2024. PMID: 39124739 Free PMC article.
-
Unawareness of breast cancer family history among African women.Pan Afr Med J. 2023 Aug 30;45:188. doi: 10.11604/pamj.2023.45.188.21616. eCollection 2023. Pan Afr Med J. 2023. PMID: 38020349 Free PMC article.
-
Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer-Experience from a Hospital in Central Taiwan.Medicina (Kaunas). 2023 Mar 29;59(4):680. doi: 10.3390/medicina59040680. Medicina (Kaunas). 2023. PMID: 37109638 Free PMC article.
-
Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system.Front Genet. 2022 Aug 11;13:886650. doi: 10.3389/fgene.2022.886650. eCollection 2022. Front Genet. 2022. PMID: 36035175 Free PMC article.
-
Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey.Prev Med. 2022 Jun;159:107062. doi: 10.1016/j.ypmed.2022.107062. Epub 2022 Apr 20. Prev Med. 2022. PMID: 35460723 Free PMC article.
References
-
- Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ. Can family history be used as a tool for public health and preventive medicine? Genet Med. 2002;4(4):304–310. - PubMed
-
- Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst. 2003;95(7):526–532. - PubMed
-
- US Preventive Services Task Force. Guide to Clinical Preventive Services. http://www.uspreventiveservicestaskforce.org/adultrec.htm#cancer. Accessed December 22, 2009.
-
- Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99–119. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
